DE69827880D1 - Iga1-protease fragment als trägerpeptid - Google Patents

Iga1-protease fragment als trägerpeptid

Info

Publication number
DE69827880D1
DE69827880D1 DE69827880T DE69827880T DE69827880D1 DE 69827880 D1 DE69827880 D1 DE 69827880D1 DE 69827880 T DE69827880 T DE 69827880T DE 69827880 T DE69827880 T DE 69827880T DE 69827880 D1 DE69827880 D1 DE 69827880D1
Authority
DE
Germany
Prior art keywords
iga1
amino acid
carrier peptide
protease fragment
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69827880T
Other languages
English (en)
Other versions
DE69827880T2 (de
Inventor
Mark Achtman
Monique Moreau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Sanofi Pasteur SA
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, Aventis Pasteur SA filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of DE69827880D1 publication Critical patent/DE69827880D1/de
Publication of DE69827880T2 publication Critical patent/DE69827880T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69827880T 1997-01-21 1998-01-20 Iga1-protease fragment als trägerpeptid Expired - Lifetime DE69827880T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97100883 1997-01-21
EP97100883 1997-01-21
PCT/EP1998/000294 WO1998031791A1 (en) 1997-01-21 1998-01-20 Iga1 protease fragment as carrier peptide

Publications (2)

Publication Number Publication Date
DE69827880D1 true DE69827880D1 (de) 2005-01-05
DE69827880T2 DE69827880T2 (de) 2005-11-03

Family

ID=8226386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827880T Expired - Lifetime DE69827880T2 (de) 1997-01-21 1998-01-20 Iga1-protease fragment als trägerpeptid

Country Status (14)

Country Link
US (1) US7235242B2 (de)
EP (1) EP0895537B1 (de)
JP (1) JP2000507274A (de)
KR (1) KR20000064740A (de)
AT (1) ATE283914T1 (de)
AU (1) AU6211698A (de)
CA (1) CA2249409C (de)
DE (1) DE69827880T2 (de)
DK (1) DK0895537T3 (de)
ES (1) ES2234095T3 (de)
NO (1) NO322265B1 (de)
NZ (1) NZ331968A (de)
PT (1) PT895537E (de)
WO (1) WO1998031791A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821859A1 (de) * 1998-05-15 1999-12-09 M Alexander Schmidt Darstellung immunogener (Kapsel-)Polysaccharid-Konjugate durch orientierte Kupplung synthetischer T-Zell-Epitope zur Erzeugung von Vakzinen gegen N.meningitidis
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
DK2976325T3 (en) 2013-03-21 2017-06-06 Sanofi Aventis Deutschland SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3622221A1 (de) 1986-07-02 1988-01-14 Max Planck Gesellschaft Verfahren zur gentechnologischen gewinnung von proteinen unter verwendung gramnegativer wirtszellen
EP0326111A3 (de) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptid-Derivate, immunogenisch gemacht bei Verabreichung zusammen mit Alaun als Zusatzmittel
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition

Also Published As

Publication number Publication date
NO984365D0 (no) 1998-09-18
US20040203108A1 (en) 2004-10-14
DE69827880T2 (de) 2005-11-03
PT895537E (pt) 2005-04-29
EP0895537A1 (de) 1999-02-10
NO984365L (no) 1998-11-19
US7235242B2 (en) 2007-06-26
CA2249409C (en) 2010-10-26
ATE283914T1 (de) 2004-12-15
CA2249409A1 (en) 1998-07-23
NZ331968A (en) 1999-05-28
NO322265B1 (no) 2006-09-04
ES2234095T3 (es) 2005-06-16
DK0895537T3 (da) 2005-03-29
JP2000507274A (ja) 2000-06-13
WO1998031791A1 (en) 1998-07-23
EP0895537B1 (de) 2004-12-01
KR20000064740A (ko) 2000-11-06
AU6211698A (en) 1998-08-07

Similar Documents

Publication Publication Date Title
DE69838143D1 (de) Antimikrobielle peptide
EP1548107A4 (de) Chromoprotein und fluoroproteine
EP1006126A3 (de) Peptide mit osteogener Aktivität
DE60237791D1 (de) Zytokinproteinfamilie
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
PL342578A1 (en) Deep-frozen article of food
AU3850997A (en) Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
PT635025E (pt) Processo para preparar proteinas modificadas
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
EP1222255A4 (de) Polypeptidfragmente mit einer c-terminalen teil von katalase aus helicobacter
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
DE69623635T2 (de) Mu-opioidligande: agonisten und antagonisten
DK0938329T3 (da) Immunogen TLP sammensætning
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
NZ606260A (en) Novel polypeptides involved in immune response
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)
ECSP982804A (es) Beta- lipotropina y usos de la misma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition